Provided by Tiger Fintech (Singapore) Pte. Ltd.

Arcutis Biotherapeutics Inc.

13.60
-0.2200-1.59%
Post-market: 13.910.3100+2.28%19:46 EDT
Volume:2.08M
Turnover:28.57M
Market Cap:1.62B
PE:-13.07
High:14.13
Open:13.94
Low:13.54
Close:13.82
Loading ...
Nov 03, 2021

Statement Of Changes In Beneficial Ownership

4 - Statement of changes in beneficial ownership of securities
Oct 07, 2021

Statement Of Changes In Beneficial Ownership

4 - Statement of changes in beneficial ownership of securities
Oct 07, 2021

Statement Of Changes In Beneficial Ownership

3/A [Amend] - Initial statement of beneficial ownership of securities
Oct 05, 2021

Statement Of Changes In Beneficial Ownership

4 - Statement of changes in beneficial ownership of securities
Oct 05, 2021

Statement Of Changes In Beneficial Ownership

4 - Statement of changes in beneficial ownership of securities
Sep 07, 2021

Major Issues Report

8-K - Current report
Aug 05, 2021

Major Issues Report

8-K - Current report
Aug 05, 2021

Quarterly Report

10-Q - Quarterly report [Sections 13 or 15(d)]
Jun 14, 2021

Major Issues Report

8-K - Current report
May 12, 2021

Beneficial Ownership Change

SC 13D/A [Amend] - General statement of acquisition of beneficial ownership
May 06, 2021

Quarterly Report

10-Q - Quarterly report [Sections 13 or 15(d)]
May 04, 2021

Major Issues Report

8-K - Current report
Apr 23, 2021

Correspondence

CORRESP [Cover] - Correspondence
Mar 26, 2021

Major Issues Report

8-K - Current report
Feb 16, 2021

Annual Report

10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
Feb 16, 2021

Major Issues Report

8-K - Current report
Feb 16, 2021

Employee Stock Ownership

S-8 - Securities to be offered to employees in employee benefit plans
Feb 09, 2021

Beneficial Ownership Change

SC 13D/A [Amend] - General statement of acquisition of beneficial ownership
Feb 09, 2021

Beneficial Ownership Change

SC 13D/A [Amend] - General statement of acquisition of beneficial ownership
Feb 08, 2021

Beneficial Ownership Change

SC 13D/A [Amend] - General statement of acquisition of beneficial ownership